accounttheir progress in reducing costs by their target of $4 billion to $5 billion per year since buying Wyeth for $68 billion in October 2009.Analysts will look for updates on progress in reviewing which Pfizer and Wyeth businesses, products and research...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Earnings Preview: Pfizer reports on first quarter
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account